|
시장보고서
상품코드
2149230
신경 의지 시장 규모, 점유율, 성장, 세계 산업 분석, 지역별 인사이트 및 예측(2026-2034년)Neuroprosthetics Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034 |
||||||
신경 의지 시장 성장요인
세계 신경 의지 시장 규모는 2025년에 110억 8,000만 달러로 평가되었습니다. 이 시장은 2026년 119억 8,000만 달러에서 2034년까지 232억 6,000만 달러로 성장하여, 2026년부터 2034년까지 연평균 성장률(CAGR) 8.6%를 기록할 것으로 예측됩니다. 북미는 선진적인 의료 인프라, 만성 통증 부담의 증가, 고령화, 그리고 지속적인 기술 혁신에 힘입어 2025년에는 45.67%의 점유율을 차지하며 전 세계 신경 의지 시장을 주도했습니다.
신경 의지란 신경계와 상호작용하여 손상된 신경 기능을 회복, 조절 또는 지원하도록 설계된 이식형 또는 체외 연결형 의료기기를 말합니다. 주요 기술로는 인공 와우, 심부 뇌 자극 시스템, 척수 자극 장치, 미주 신경 자극 장치 및 뇌-컴퓨터 인터페이스가 포함됩니다. 신경 질환의 증가, 기술 발전, 그리고 보험 급여 기회 확대가 시장 성장을 뒷받침하고 있습니다.
연도별 시장 규모 및 시장 가치
- 2025년 : 110억 8,000만 달러
- 2026년 : 119억 8,000만 달러
- 2034년 : 232억 6,000만 달러
- 2026-2034년 연평균 성장률(CAGR) : 8.6%
시장의 정의 및 범위
신경 의지 시장은 침습적, 최소침습적 또는 비침습적 기법을 통해 신경 경로와 상호작용하는 기기 및 기술을 대상으로 합니다. 이 시장은 제품 유형, 기술, 용도 및 최종사용자별로 세분화되어 있으며, 통증 관리, 감각 기능 회복, 운동 장애, 정신 질환 및 인지 장애 등의 용도를 포괄합니다.
시장 역학
시장 촉진요인 : 파킨슨병, 간질, 척수 손상, 만성 통증 등 신경 질환으로 인한 부담이 증가함에 따라 신경 의지 기술에 대한 수요가 높아지고 있습니다. 또한, 신경 인터페이스의 발전으로 치료 능력도 향상되고 있습니다. 예를 들어, Epsilon Medical사는 2025년 5월, 자사의 EP-01 혈관 내 뇌파(EEG) 기기에 대해 FDA 승인을 획득했습니다.
시장 억제요인 : 기기, 이식 수술 및 유지 관리에 드는 높은 비용이 여전히 큰 장벽으로 작용하고 있습니다. 많은 신경 의지 시스템은 전문 외과의사, 첨단 장비, 그리고 장기적인 추적 관찰이 필요합니다. 또한, 보험 적용 범위의 불균일성도 환자의 부담을 가중시키고, 신흥 시장에서 활용 기회를 제한하는 요인이 되고 있습니다.
시장 기회 : 최소침습 및 비침습형 기기에 대한 수요가 증가하면서 새로운 기회가 창출되고 있습니다. 각 기업은 웨어러블 자극 장치, 표면 전극, 비침습형 뇌-컴퓨터 인터페이스(BCI), 그리고 소형 신경 조절 기술을 개발하고 있습니다. 2025년 10월, 옥스퍼드 대학교의 NeuroMetrology Lab과 Clario사는 파킨슨병 분석을 위한 웨어러블 센서 기술에 초점을 맞춘 제휴를 발표했습니다.
시장 동향 : 네트워크 연결이 가능하고 지능형인 신경 의지 기기의 중요성이 커지고 있습니다. 센서, 마이크로칩, 소프트웨어, AI 기반 기술의 발전으로 인해 기기는 신경 신호나 환자의 반응을 실시간으로 모니터링하여 치료의 개인화가 가능해지고 있습니다.
시장 과제 : 안전성, 윤리적 고려 사항, 규제 요건, 개인정보 보호에 대한 우려, 그리고 새로운 뇌-컴퓨터 인터페이스 기술에 대한 장기 데이터 부족이 도입을 저해할 가능성이 있습니다.
목차
제1장 소개
제2장 주요 요약
제3장 시장 역학
제4장 주요 인사이트
제5장 세계의 신경 의지 시장 분석, 인사이트, 예측, 2019-2032년
제6장 북미의 신경 의지 시장 분석, 인사이트, 예측, 2019-2032년
제7장 유럽의 신경 의지 시장 분석, 인사이트, 예측, 2019-2032년
제8장 아시아태평양의 신경 의지 시장 분석, 인사이트, 예측, 2019-2032년
제9장 라틴아메리카의 신경 의지 시장 분석, 인사이트, 예측, 2019-2032년
제10장 중동 및 아프리카의 신경 의지 시장 분석, 인사이트, 예측, 2019-2032년
제11장 경쟁 분석
KSM 26.10.22Growth Factors of neuroprosthetics Market
The global neuroprosthetics market size was valued at USD 11.08 billion in 2025. The market is projected to grow from USD 11.98 billion in 2026 to USD 23.26 billion by 2034, exhibiting a CAGR of 8.6% from 2026 to 2034. North America dominated the global neuroprosthetics market with a 45.67% share in 2025, supported by advanced healthcare infrastructure, a growing chronic pain burden, an aging population, and continued technological innovation.
Neuroprosthetics are implantable or externally connected medical devices designed to restore, regulate, or support damaged neural functions by interacting with the nervous system. Major technologies include cochlear implants, deep brain stimulation systems, spinal cord stimulators, vagus nerve stimulators, and brain-computer interfaces. Rising neurological disorders, technological advancements, and improving reimbursement opportunities are supporting market expansion.
Market Size and Value by Year
- 2025: USD 11.08 billion
- 2026: USD 11.98 billion
- 2034: USD 23.26 billion
- CAGR, 2026-2034: 8.6%
Market Definition and Scope
The neuroprosthetics market covers devices and technologies that interact with neural pathways through invasive, minimally invasive, or non-invasive approaches. The market is segmented by product type, technology, application, and end-user, covering applications such as pain management, sensory restoration, movement disorders, and psychiatric and cognitive disorders.
Market Dynamics
Market Drivers: The rising burden of neurological disorders, including Parkinson's disease, epilepsy, spinal cord injuries, and chronic pain, is increasing demand for neuroprosthetic technologies. Advances in neural interfaces are also improving treatment capabilities. For example, Epsilon Medical received FDA approval for its EP-01 endovascular EEG device in May 2025.
Market Restraints: High device, implantation, and maintenance costs remain a major barrier. Many neuroprosthetic systems require specialized surgeons, sophisticated equipment, and long-term follow-up. Uneven insurance coverage can also increase patient expenses and limit accessibility in emerging markets.
Market Opportunities: Increasing preference for minimally invasive and non-invasive devices is creating new opportunities. Companies are developing wearable stimulators, surface electrodes, non-invasive brain-computer interfaces, and compact neuromodulation technologies. In October 2025, Oxford's NeuroMetrology Lab and Clario announced a partnership focused on wearable sensor technology for Parkinson's disease analysis.
Market Trends: Connected and intelligent neuroprosthetic devices are becoming increasingly important. Better sensors, microchips, software, and AI-based technologies allow devices to monitor neural signals and patient responses in real time and potentially personalize treatment.
Market Challenges: Safety, ethical considerations, regulatory requirements, privacy concerns, and limited long-term data for newer brain-computer interface technologies can slow adoption.
Segmentation Analysis
By Product Type: Spinal cord stimulators accounted for the largest share in 2025, supported by extensive use in chronic pain management. Deep brain stimulation systems are projected to grow at a 9.4% CAGR.
By Technology: Invasive neuroprosthetics dominated the market and are expected to hold an 82.4% share in 2026 because of established clinical applications such as deep brain stimulation, cochlear implants, and spinal cord stimulation. Non-invasive neuroprosthetics are projected to grow at a 9.7% CAGR.
By Application: Pain management dominated in 2025 and is expected to hold a 35.6% share in 2026, supported by the prevalence of chronic pain and adoption of non-drug treatment options. Psychiatric and cognitive disorders are projected to grow at a 10.4% CAGR.
By End-User: Hospitals and clinics represented the leading end-user segment in 2025 and are expected to hold a 68.6% share in 2026, owing to the specialized resources required for implantation and long-term patient management.
Regional Insights
North America: North America led the market with USD 5.06 billion in 2025, compared with USD 4.69 billion in 2024. The U.S. market is estimated to reach USD 5.51 billion in 2026.
Europe: Europe is projected to grow at a 7.6% CAGR and reach USD 3.08 billion in 2026. The U.K., Germany, and France are estimated at USD 0.50 billion, USD 0.69 billion, and USD 0.41 billion, respectively, in 2026.
Asia Pacific: Asia Pacific is expected to reach USD 2.63 billion in 2026, becoming the third-largest regional market. China and India are estimated at USD 0.87 billion and USD 0.58 billion, respectively.
Latin America and Middle East & Africa: Latin America is projected to reach USD 0.59 billion in 2026, while the GCC is expected to reach USD 0.11 billion.
Competitive Landscape
Major companies include Medtronic plc, Boston Scientific Corporation, Cochlear Limited, Abbott Laboratories, LivaNova PLC, MED-EL Medical Electronics, Sonova Holding AG, NeuroPace, Nevro Corp., and Blackrock Neurotech. Competition is driven by product innovation, strategic partnerships, acquisitions, collaborations, and expansion into emerging markets.
Recent developments include Neuros Medical's first Altius implant in July 2025, Abbott's new electrode delivery system in April 2025, Newronika's CE approval for AlphaDBS in March 2025, Medtronic's FDA approval for an adaptive deep brain stimulation technology in February 2025, and Saluda Medical's FDA approval for its biomarker-based programming platform in January 2025.
Report Coverage
The report covers neuroprosthetics market size and forecast, product types, technologies, applications, end-users, regional markets, market drivers, restraints, opportunities, trends, challenges, competitive developments, product launches, partnerships, and major industry players.
Conclusion
The global neuroprosthetics market is expanding as neurological disorders, chronic pain, and the need for advanced neural therapies increase worldwide. The market is valued at USD 11.08 billion in 2025, projected to reach USD 11.98 billion in 2026, and expected to reach USD 23.26 billion by 2034. North America remains the leading regional market, while advances in AI, connected devices, minimally invasive technologies, and personalized neural stimulation are creating additional opportunities. Continued innovation, improved clinical outcomes, and broader access to neuroprosthetic technologies are expected to support market development through 2034.
Segmentation By Product Type, Technology, Application, End-user, and Region
By Product Type
- Cochlear Implants
- Deep brain stimulation (DBS) systems
- Spinal cord stimulators
- Vagus nerve stimulators
- Others
By Technology
- Invasive Neuroprosthetics
- Non-invasive Neuroprosthetics
- Minimally Invasive Neuroprosthetics
By Application
- Motor Function & Movement Disorders
- Sensory Restoration
- Pain Management
- Psychiatric & Cognitive Disorders
- Others
By End-user
- Hospitals & Clinics
- Academic & Research Institutes
- Others
By Region
- North America (By Product Type, Technology, Application, End-user, and Country)
- U.S. (By Product Type)
- Canada (By Product Type)
- Europe (By Product Type, Technology, Application, End-user, and Country/Sub-region)
- Germany (By Product Type)
- U.K. (By Product Type)
- France (By Product Type)
- Spain (By Product Type)
- Italy (By Product Type)
- Scandinavia (By Product Type)
- Rest of Europe (By Product Type)
- Asia Pacific (By Product Type, Technology, Application, End-user, and Country/Sub-region)
- China (By Product Type)
- Japan (By Product Type)
- India (By Product Type)
- Australia (By Product Type)
- Southeast Asia (By Product Type)
- Rest of Asia Pacific (By Product Type)
- Latin America (By Size, Procedure, End-user, and Country/Sub-region)
- Brazil (By Product Type)
- Mexico (By Product Type)
- Rest of Latin America (By Product Type)
- Middle East & Africa (By Product Type, Technology, Application, End-user, and Country/Sub-region)
- GCC (By Product Type)
- South Africa (By Product Type)
- Rest of the Middle East & Africa (By Product Type)
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2023/2024
- 4.2. Technological Advancements in Neuroprosthetics
- 4.3. New Product Launches, Key Players
- 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships
5. Global Neuroprosthetics Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast - By Product Type
- 5.1.1. Cochlear Implants
- 5.1.2. Deep Brain Stimulation (DBS) Systems
- 5.1.3. Spinal Cord Stimulators
- 5.1.4. Vagus Nerve Stimulators
- 5.1.5. Others
- 5.2. Market Analysis, Insights and Forecast - By Technology
- 5.2.1. Invasive Neuroprosthetics
- 5.2.2. Non-invasive Neuroprosthetics
- 5.2.3. Minimally Invasive Neuroprosthetics
- 5.3. Market Analysis, Insights and Forecast - By Application
- 5.3.1. Motor Function & Movement Disorders
- 5.3.2. Sensory Restoration
- 5.3.3. Pain Management
- 5.3.4. Psychiatric & Cognitive Disorders
- 5.3.5. Others
- 5.4. Market Analysis, Insights and Forecast - By End-user
- 5.4.1. Hospitals & Clinics
- 5.4.2. Academic & Research Institutes
- 5.4.3. Others
- 5.5. Market Analysis, Insights and Forecast - By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East and Africa
6. North America Neuroprosthetics Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast - By Product Type
- 6.1.1. Cochlear Implants
- 6.1.2. Deep Brain Stimulation (DBS) Systems
- 6.1.3. Spinal Cord Stimulators
- 6.1.4. Vagus Nerve Stimulators
- 6.1.5. Others
- 6.2. Market Analysis, Insights and Forecast - By Technology
- 6.2.1. Invasive Neuroprosthetics
- 6.2.2. Non-invasive Neuroprosthetics
- 6.2.3. Minimally Invasive Neuroprosthetics
- 6.3. Market Analysis, Insights and Forecast - By Application
- 6.3.1. Motor Function & Movement Disorders
- 6.3.2. Sensory Restoration
- 6.3.3. Pain Management
- 6.3.4. Psychiatric & Cognitive Disorders
- 6.3.5. Others
- 6.4. Market Analysis, Insights and Forecast - By End-user
- 6.4.1. Hospitals & Clinics
- 6.4.2. Academic & Research Institutes
- 6.4.3. Others
- 6.5. Market Analysis, Insights and Forecast - By Country
- 6.5.1. U.S.
- 6.5.1.1. By Product Type
- 6.5.2. Canada
- 6.5.2.1. By Product Type
- 6.5.1. U.S.
7. Europe Neuroprosthetics Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast - By Product Type
- 7.1.1. Cochlear Implants
- 7.1.2. Deep Brain Stimulation (DBS) Systems
- 7.1.3. Spinal Cord Stimulators
- 7.1.4. Vagus Nerve Stimulators
- 7.1.5. Others
- 7.2. Market Analysis, Insights and Forecast - By Technology
- 7.2.1. Invasive Neuroprosthetics
- 7.2.2. Non-invasive Neuroprosthetics
- 7.2.3. Minimally Invasive Neuroprosthetics
- 7.3. Market Analysis, Insights and Forecast - By Application
- 7.3.1. Motor Function & Movement Disorders
- 7.3.2. Sensory Restoration
- 7.3.3. Pain Management
- 7.3.4. Psychiatric & Cognitive Disorders
- 7.3.5. Others
- 7.4. Market Analysis, Insights and Forecast - By End-user
- 7.4.1. Hospitals & Clinics
- 7.4.2. Academic & Research Institutes
- 7.4.3. Others
- 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.5.1. U.K.
- 7.5.1.1. By Product Type
- 7.5.2. Germany
- 7.5.2.1. By Product Type
- 7.5.3. France
- 7.5.3.1. By Product Type
- 7.5.4. Spain
- 7.5.4.1. By Product Type
- 7.5.5. Italy
- 7.5.5.1. By Product Type
- 7.5.6. Scandinavia
- 7.5.6.1. By Product Type
- 7.5.7. Rest of Europe
- 7.5.7.1. By Product Type
- 7.5.1. U.K.
8. Asia Pacific Neuroprosthetics Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast - By Product Type
- 8.1.1. Cochlear Implants
- 8.1.2. Deep Brain Stimulation (DBS) Systems
- 8.1.3. Spinal Cord Stimulators
- 8.1.4. Vagus Nerve Stimulators
- 8.1.5. Others
- 8.2. Market Analysis, Insights and Forecast - By Technology
- 8.2.1. Invasive Neuroprosthetics
- 8.2.2. Non-invasive Neuroprosthetics
- 8.2.3. Minimally Invasive Neuroprosthetics
- 8.3. Market Analysis, Insights and Forecast - By Application
- 8.3.1. Motor Function & Movement Disorders
- 8.3.2. Sensory Restoration
- 8.3.3. Pain Management
- 8.3.4. Psychiatric & Cognitive Disorders
- 8.3.5. Others
- 8.4. Market Analysis, Insights and Forecast - By End-user
- 8.4.1. Hospitals & Clinics
- 8.4.2. Academic & Research Institutes
- 8.4.3. Others
- 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.5.1. Japan
- 8.5.1.1. By Product Type
- 8.5.2. Australia
- 8.5.2.1. By Product Type
- 8.5.3. China
- 8.5.3.1. By Product Type
- 8.5.4. India
- 8.5.4.1. By Product Type
- 8.5.5. Southeast Asia
- 8.5.5.1. By Product Type
- 8.5.6. Rest of Asia Pacific
- 8.5.6.1. By Product Type
- 8.5.1. Japan
9. Latin America Neuroprosthetics Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast - By Product Type
- 9.1.1. Cochlear Implants
- 9.1.2. Deep Brain Stimulation (DBS) Systems
- 9.1.3. Spinal Cord Stimulators
- 9.1.4. Vagus Nerve Stimulators
- 9.1.5. Others
- 9.2. Market Analysis, Insights and Forecast - By Technology
- 9.2.1. Invasive Neuroprosthetics
- 9.2.2. Non-invasive Neuroprosthetics
- 9.2.3. Minimally Invasive Neuroprosthetics
- 9.3. Market Analysis, Insights and Forecast - By Application
- 9.3.1. Motor Function & Movement Disorders
- 9.3.2. Sensory Restoration
- 9.3.3. Pain Management
- 9.3.4. Psychiatric & Cognitive Disorders
- 9.3.5. Others
- 9.4. Market Analysis, Insights and Forecast - By End-user
- 9.4.1. Hospitals & Clinics
- 9.4.2. Academic & Research Institutes
- 9.4.3. Others
- 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.5.1. Brazil
- 9.5.1.1. By Product Type
- 9.5.2. Mexico
- 9.5.2.1. By Product Type
- 9.5.3. Rest of Latin America
- 9.5.3.1. By Product Type
- 9.5.1. Brazil
10. Middle East and Africa Neuroprosthetics Market Analysis, Insights and Forecast, 2019-2032
- 10.1. Market Analysis, Insights and Forecast - By Product Type
- 10.1.1. Cochlear Implants
- 10.1.2. Deep Brain Stimulation (DBS) Systems
- 10.1.3. Spinal Cord Stimulators
- 10.1.4. Vagus Nerve Stimulators
- 10.1.5. Others
- 10.2. Market Analysis, Insights and Forecast - By Technology
- 10.2.1. Invasive Neuroprosthetics
- 10.2.2. Non-invasive Neuroprosthetics
- 10.2.3. Minimally Invasive Neuroprosthetics
- 10.3. Market Analysis, Insights and Forecast - By Application
- 10.3.1. Motor Function & Movement Disorders
- 10.3.2. Sensory Restoration
- 10.3.3. Pain Management
- 10.3.4. Psychiatric & Cognitive Disorders
- 10.3.5. Others
- 10.4. Market Analysis, Insights and Forecast - By End-user
- 10.4.1. Hospitals & Clinics
- 10.4.2. Academic & Research Institutes
- 10.4.3. Others
- 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.5.1. South Africa
- 10.5.1.1. By Product Type
- 10.5.2. GCC
- 10.5.2.1. By Product Type
- 10.5.3. Rest of Middle East and Africa
- 10.5.3.1. By Product Type
- 10.5.1. South Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2024)
- 11.2. Company Profiles
- 11.2.1. Medtronic plc (Ireland)
- 11.2.2. Boston Scientific Corporation (U.S.)
- 11.2.3. Cochlear Limited (Australia)
- 11.2.4. Abbott Laboratories (U.S.)
- 11.2.5. LivaNova PLC (U.K.)
- 11.2.6. MED-EL Medical Electronics (Austria)
- 11.2.7. Sonova Holding AG (Switzerland)
- 11.2.8. NeuroPace, Inc. (U.S.)
- 11.2.9. Nevro Corp. (U.S.)
